CIP2A and neoplasm: Consistent with its oncogenic role, overexpression of CIP2A has been found in several tumor types, including ovarian, colon and non–small cell lung carcinoma, as well as in chronic myelogenous leukemia, where it is associated with disease progression and prognostic variables 5,8–15.